Our top pick for
Beginners
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Akumin stock
Own Akumin stock in just a few minutes.
Fact checked
Akumin Inc is a diagnostics & research business based in the US. Akumin shares (AKU) are listed on the NASDAQ and all prices are listed in US Dollars. Akumin employs 1,737 staff and has a trailing 12-month revenue of around USD$269 million.
How to buy shares in Akumin
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for Akumin. Find the stock by name or ticker symbol: AKU. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Akumin reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Akumin, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Akumin. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Akumin share price
Use our graph to track the performance of AKU stocks over time.Akumin shares at a glance
Information last updated 2021-03-03.
| 52-week range | USD$2.7 - USD$3.78 |
|---|---|
| 50-day moving average | USD$3.2568 |
| 200-day moving average | USD$3.258 |
| Wall St. target price | USD$4.81 |
| PE ratio | 72 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | N/A |
Buy Akumin shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Akumin stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Is Akumin under- or over-valued?
Valuing Akumin stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Akumin's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Akumin's P/E ratio
Akumin's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 72x. In other words, Akumin shares trade at around 72x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Akumin's EBITDA
Akumin's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$70.5 million.
The EBITDA is a measure of a Akumin's overall financial performance and is widely used to measure a its profitability.
Akumin financials
| Revenue TTM | USD$269 million |
|---|---|
| Operating margin TTM | 18.78% |
| Gross profit TTM | USD$142.5 million |
| Return on assets TTM | 4.77% |
| Return on equity TTM | 1.37% |
| Profit margin | -0.25% |
| Book value | N/A |
| Market capitalisation | USD$254.5 million |
TTM: trailing 12 months
Shorting Akumin shares
There are currently 9,512 Akumin shares held short by investors – that's known as Akumin's "short interest". This figure is 1.8% up from 9,342 last month.
There are a few different ways that this level of interest in shorting Akumin shares can be evaluated.
Akumin's "short interest ratio" (SIR)
Akumin's "short interest ratio" (SIR) is the quantity of Akumin shares currently shorted divided by the average quantity of Akumin shares traded daily (recently around 95120). Akumin's SIR currently stands at 0.1. In other words for every 100,000 Akumin shares traded daily on the market, roughly 100 shares are currently held short.
However Akumin's short interest can also be evaluated against the total number of Akumin shares, or, against the total number of tradable Akumin shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Akumin's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Akumin shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Akumin shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Akumin.
Find out more about how you can short Akumin stock.
Akumin share dividends
We're not expecting Akumin to pay a dividend over the next 12 months.
Akumin share price volatility
Over the last 12 months, Akumin's shares have ranged in value from as little as $2.7 up to $3.78. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Akumin's is 1.3819. This would suggest that Akumin's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Akumin overview
Akumin Inc. provides outpatient diagnostic imaging services in the United States. As of December 31, 2019, the company operated 129 imaging centers located in Florida, Pennsylvania, Delaware, Georgia, Texas, Illinois, and Kansas. Its centers offer physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders, and reduce unnecessary invasive procedures. The company provides a range of medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, radiology, and other diagnostic or interventional radiology procedures; and online medical bill payment services. Akumin Inc. is headquartered in Toronto, Canada.
Frequently asked questions
More guides on Finder
-
How to buy Hayward Holdings Inc (HAYW) stock when it goes public
Everything we know about the Hayward Holdings Inc IPO, plus information on how to buy in.
-
How to buy Alignment Healthcare Inc (ALHC) stock when it goes public
Everything we know about the Alignment Healthcare Inc IPO, plus information on how to buy in.
-
How to buy Olink Holding AB (publ) (OLK) stock when it goes public
Everything we know about the Olink Holding AB (publ) IPO, plus information on how to buy in.
-
How to buy Procore (PCOR) stock when it goes public
Everything we know about the Procore IPO, plus information on how to buy in.
-
How to buy Navios South American Logistics Inc (NSAL) stock when it goes public
Everything we know about the Navios South American Logistics Inc IPO, plus information on how to buy in.
-
How to buy Lava Therapeutics (LVRX) stock when it goes public
Everything we know about the Lava Therapeutics IPO, plus information on how to buy in.
-
How to buy Pop Culture Group Co Ltd (CPOP) stock when it goes public
Everything we know about the Pop Culture Group Co Ltd IPO, plus information on how to buy in.
-
How to buy Bukalapak (AKU.US) stock when it goes public
Everything we know about the Bukalapak IPO, plus information on how to buy in.
-
How to buy Achilles Therapeutics plc (ACHL) stock when it goes public
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
-
How to buy SEMrush Holdings Inc (SEMR) stock when it goes public
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
Ask an Expert